Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) - Global Forecast to 2025
The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period. Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.
“In terms Purchase mode, OTC segment to register significant growth during the forecast period..”
Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.
In terms Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020.”
Based on the application, the fertility test market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.
“In terms of product segment, ovulation prediction kits segment is expected to account for the largest share during the forecast period.”
Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products. Large share is attributed to ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.
“The home care settings segment is expected to register the highest CAGR during the forecast period” `
Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.
“Asia Pacific market is expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific market is projected to register the highest CAGR during the forecast period. Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the fertility test market based on application, mode of purchase, by products, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions and their respective major countries.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the fertility test market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the fertility test market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the fertility test market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
“In terms Purchase mode, OTC segment to register significant growth during the forecast period..”
Based on the mode of purchase, the fertility test market is segmented into direct/prescription, OTC, and online products. In 2020 the OTC segment had the major market share and exibited high growth. The high growth of this segment is attributed to the inclination of patients towards self-monitoring of healthcare conditions, increasing initiatives by market players to spread awareness on fertility, and the rising preference for confidentiality and accessibility of test results.
In terms Application, the female fertility testing segment is expected to account for the largest share of the fertility test market in 2020.”
Based on the application, the fertility test market is segmented into female fertility testing and male fertility testing. In 2020, the female fertility testing segment accounted for a larger market share, primarily due to the decreasing female fertility rates, availability of a wide range of fertility testing options for females, increase in gynecological issues in women (such as PCOD/PCOS), and the high cost of IVF procedures.
“In terms of product segment, ovulation prediction kits segment is expected to account for the largest share during the forecast period.”
Based on products, the fertility test market is segmented into ovulation prediction kits, fertility monitors & male fertility testing products. Large share is attributed to ovulation prediction kits segment due to the increasing use of ovulation prediction kits, easy over-the-counter availability and low cost, and higher accuracy than natural fertility testing techniques, such as calendar methods and cervical mucus monitoring.
“The home care settings segment is expected to register the highest CAGR during the forecast period” `
Based on end-users, the fertility test market has been segmented based on end-user category—home care settings, hospitals and fertility clinics, and other end users. The large share and high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions, easy access to fertility and ovulation monitors on e-commerce websites, availability of user-friendly and easy-to-handle devices, and the growing preference for the confidentiality of test results.
“Asia Pacific market is expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific market is projected to register the highest CAGR during the forecast period. Growth in the Asia Pacific market is majorly due to the growing number of women suffering from lifestyle disorders, increasing funding/investments toward the development of fertility and ovulation monitors, and the growing focus of both international and domestic players on the Asia Pacific fertility test market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Research Coverage
This report studies the fertility test market based on application, mode of purchase, by products, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions and their respective major countries.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the fertility test market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the fertility test market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the fertility test market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 VOLUME-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: FERTILITY TEST MARKET
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 8 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 FERTILITY TEST MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 FERTILITY TEST MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE FERTILITY TEST MARKET
4 PREMIUM INSIGHTS
4.1 FERTILITY TEST MARKET OVERVIEW
FIGURE 13 INCREASING FIRST-TIME PREGNANCY AGE TO DRIVE MARKET GROWTH
4.2 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 14 OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE MARKET IN 2025
4.3 APAC FERTILITY TEST MARKET SHARE, BY COUNTRY AND APPLICATION (2020)
FIGURE 15 FEMALE FERTILITY TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC FERTILITY TEST MARKET IN 2020
4.4 FERTILITY TEST MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 16 HOME CARE SETTINGS ARE THE LARGEST END USERS OF FERTILITY TESTING PRODUCTS
4.5 FERTILITY TEST MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing first-time pregnancy age
5.2.1.2 Declining fertility rates across the globe
FIGURE 19 DECLINE IN FERTILITY RATE IN THE US, 2008–2018
5.2.1.3 Growing population of women of reproductive age
5.2.1.4 Launch of advanced, easy-to-use fertility testing devices with high accuracy
5.2.1.5 Increasing awareness of fertility testing
5.2.1.6 Growing number of gynecological and reproductive issues in women and men
5.2.2 RESTRAINTS
5.2.2.1 Lesser precision of ovulation prediction kits
5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/
PCOD patients
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation
5.2.3.2 Emerging nations to offer new growth avenues
5.2.3.3 Online sales of fertility testing devices
5.2.3.4 High cost and low accuracy of IVF treatment
TABLE 1 COST OF IVF ACROSS VARIOUS COUNTRIES
5.2.4 CHALLENGES
5.2.4.1 High cost of fertility testing monitors
5.3 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
5.4 REGULATORY ANALYSIS
5.4.1 US
TABLE 2 US FDA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 20 US: REGULATORY PROCESS FOR IVD DEVICES
5.4.2 CANADA
TABLE 3 CANADA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.3 EUROPE
TABLE 4 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 22 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
5.4.4 JAPAN
TABLE 5 CLASSIFICATION OF IVD REAGENTS IN JAPAN
5.4.5 CHINA
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 7 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.6 INDIA
FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES
5.5 VALUE CHAIN ANALYSIS
5.6 PRICING TREND ANALYSIS
TABLE 8 AVERAGE PRICE OF FERTILITY TESTING PRODUCTS, BY COUNTRY, 2020 (USD)
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 OVERVIEW
TABLE 9 FERTILITY TEST MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.2 THREAT OF NEW ENTRANTS
FIGURE 24 THREAT OF NEW ENTRANTS
5.7.3 THREAT OF SUBSTITUTES
FIGURE 25 THREAT OF SUBSTITUTES
5.7.4 BARGAINING POWER OF SUPPLIERS
FIGURE 26 BARGAINING POWER OF SUPPLIERS
5.7.5 BARGAINING POWER OF BUYERS
FIGURE 27 BARGAINING POWER OF BUYERS
5.7.6 DEGREE OF COMPETITION
FIGURE 28 DEGREE OF COMPETITION
5.8 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE
(AS OF 2019)
TABLE 10 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
5.9 COVID-19 IMPACT
6 FERTILITY TEST MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 OVULATION PREDICTION KITS
6.2.1 LOW COST AND EASY AVAILABILITY OF OVULATION PREDICTION KITS TO DRIVE THEIR ADOPTION
TABLE 12 OVULATION PREDICTION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 OVULATION PREDICTION KITS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 14 OVULATION PREDICTION KITS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 15 OVULATION PREDICTION KITS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3 FERTILITY MONITORS
TABLE 16 FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 17 FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 19 FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 20 FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.1 URINE-BASED FERTILITY MONITORS
6.3.1.1 Lower user-interpretation errors and fast and accurate results are advantages offered by urine-based monitors
TABLE 21 URINE-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 URINE-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 23 URINE-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 URINE-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.2 SALIVA-BASED FERTILITY MONITORS
6.3.2.1 Saliva-based monitors offer cost-effectiveness and better hygiene
TABLE 25 SALIVA-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 SALIVA-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 27 SALIVA-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 28 SALIVA-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.3 BLOOD-BASED FERTILITY MONITORS
6.3.3.1 Cost-effectiveness of blood-based monitors is expected to drive their adoption
TABLE 29 BLOOD-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 BLOOD-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 31 BLOOD-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 32 BLOOD-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.4 OTHER FERTILITY MONITORS
TABLE 33 OTHER FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 OTHER FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 35 OTHER FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 36 OTHER FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.4 MALE FERTILITY TESTING PRODUCTS
6.4.1 MALE FERTILITY TESTING PRODUCTS TO ACCOUNT FOR THE LOWEST SHARE OF THE MARKET
TABLE 37 MALE FERTILITY TESTING PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 MALE FERTILITY TESTING PRODUCTS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 39 MALE FERTILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 40 MALE FERTILITY TESTING PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
7 FERTILITY TEST MARKET, BY MODE OF PURCHASE
7.1 INTRODUCTION
TABLE 41 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
7.2 DIRECT/PRESCRIPTION PRODUCTS
7.2.1 AVAILABILITY OF INSURANCE COVERAGE FOR PRESCRIPTION REFILLS WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 42 DIRECT/PRESCRIPTION PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 OTC PRODUCTS
7.3.1 TREND OF SELF-MONITORING AND REMOTE ACCESS WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 43 OTC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 ONLINE PRODUCTS
7.4.1 INCREASING NUMBER OF E-PHARMACY PLATFORMS BOOSTING THE GROWTH OF THIS SEGMENT
TABLE 44 ONLINE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 FERTILITY TEST MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 45 FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 FEMALE FERTILITY TESTING
8.2.1 RISING PREVALENCE OF PCOD/PCOS WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 46 GLOBAL BURDEN OF PCOS, 2019 (PER MILLION)
TABLE 47 FERTILITY TEST MARKET FOR FEMALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
8.3 MALE FERTILITY TESTING
8.3.1 GROWING ADOPTION OF ADVANCED FERTILITY DEVICES TO AID THE GROWTH OF THIS SEGMENT
TABLE 48 FERTILITY TEST MARKET FOR MALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
9 FERTILITY TEST MARKET, BY END USER
9.1 INTRODUCTION
TABLE 49 FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 HOME CARE SETTINGS
9.2.1 EASY ACCESS TO FERTILITY TESTING PRODUCTS THROUGH E-COMMERCE WEBSITES WILL STIMULATE THE GROWTH OF THIS SEGMENT
TABLE 50 FERTILITY TEST MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2025 (USD MILLION)
9.3 HOSPITALS AND FERTILITY CENTERS
9.3.1 INCREASING NUMBER OF FERTILITY CENTERS TO BOOST THE GROWTH OF THIS SEGMENT
TABLE 51 FERTILITY TEST MARKET FOR HOSPITALS AND FERTILITY CENTERS, BY REGION, 2018–2025 (USD MILLION)
9.4 OTHER END USERS
TABLE 52 FERTILITY TEST MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
10 FERTILITY TEST MARKET, BY REGION
10.1 INTRODUCTION
TABLE 53 FERTILITY TEST MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: FERTILITY TEST MARKET SNAPSHOT
TABLE 54 NORTH AMERICA: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 56 NORTH AMERICA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 High incidence of PCOD/PCOS will boost the growth of this market
TABLE 60 US: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 61 US: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Decreasing fertility rate and the increasing mean age of first-time pregnancies driving the market
TABLE 62 CANADA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 63 CANADA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 64 EUROPE: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 69 EUROPE: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing fertility concerns and awareness to drive market growth in Germany
TABLE 70 GERMANY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Government initiatives and promotion of lab-based testing will stimulate market growth
TABLE 72 UK: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 73 UK: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing reforms for the management of POC tests to drive market growth in France
TABLE 74 FRANCE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 75 FRANCE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Decreasing fertility rates to drive the adoption of fertility testing devices in Italy
TABLE 76 ITALY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 77 ITALY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing awareness of fertility testing products among women to drive market growth
TABLE 78 SPAIN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 SPAIN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 80 ROE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 ROE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: FERTILITY TEST MARKET SNAPSHOT
TABLE 82 ASIA PACIFIC: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 ASIA PACIFIC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing average age of first-time pregnancies to drive market growth
TABLE 88 JAPAN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China dominated the Asia Pacific fertility test market in 2020
TABLE 90 CHINA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 CHINA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing prevalence of PCOD/PCOS to drive market growth in India
TABLE 92 INDIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 93 INDIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Supportive government initiatives and rising investments to drive market growth
TABLE 94 AUSTRALIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 95 AUSTRALIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Supportive government initiatives expected to positively impact market growth
TABLE 96 SOUTH KOREA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 SOUTH KOREA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 98 ROAPAC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 ROAPAC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5 LATIN AMERICA
TABLE 100 LATAM: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 LATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 102 LATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 LATAM: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 104 LATAM: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 105 LATAM: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Shrinking population concerns will drive market growth
TABLE 106 BRAZIL: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 107 BRAZIL: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing population to drive market growth in Mexico
TABLE 108 MEXICO: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 109 MEXICO: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 110 ROLATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 ROLATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES ARE EXPECTED TO RESTRAIN MARKET GROWTH IN MEA
TABLE 112 MEA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 113 MEA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 MEA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 115 MEA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 MEA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY STRATEGIES
11.3 GLOBAL MARKET SHARE ANALYSIS (2019)
TABLE 117 FERTILITY TEST MARKET: DEGREE OF COMPETITION
FIGURE 31 SWISS PRECISION DIAGNOSTICS HELD THE LEADING POSITION IN THE FERTILITY TEST MARKET IN 2020
11.4 COMPETITIVE LEADERSHIP MAPPING
11.5 VENDOR INCLUSION CRITERIA
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/
START-UPS (2019)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 33 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
11.7 COMPANY PRODUCT FOOTPRINT ANALYSIS
TABLE 118 PRODUCT FOOTPRINT OF COMPANIES
TABLE 119 APPLICATION FOOTPRINT OF COMPANIES
TABLE 120 REGIONAL FOOTPRINT OF COMPANIES
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
TABLE 121 FERTILITY TEST MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, 2017–2020
11.8.2 EXPANSIONS
TABLE 122 FERTILITY TEST MARKET: EXPANSIONS, 2017–2020
11.8.3 OTHER STRATEGIES
TABLE 123 FERTILITY TEST MARKET: OTHER STRATEGIES, 2017–2020
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1.1 SWISS PRECISION DIAGNOSTICS
TABLE 124 SWISS PRECISION DIAGNOSTICS: BUSINESS OVERVIEW
TABLE 125 SWISS PRECISION DIAGNOSTICS: PRODUCTS OFFERED
TABLE 126 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
12.1.2 CHURCH & DWIGHT
TABLE 127 CHURCH & DWIGHT: BUSINESS OVERVIEW
FIGURE 34 CHURCH & DWIGHT: COMPANY SNAPSHOT (2020)
TABLE 128 CHURCH & DWIGHT: PRODUCTS OFFERED
12.1.3 PRESTIGE BRANDS HOLDINGS
TABLE 129 PRESTIGE BRANDS HOLDINGS: BUSINESS OVERVIEW
TABLE 130 PRESTIGE BRANDS HOLDINGS: PRODUCTS OFFERED
TABLE 131 FERTILITY TESTS MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.4 BIOZHENA
TABLE 132 BIOZHENA: BUSINESS OVERVIEW
TABLE 133 BIOZHENA: PRODUCTS OFFERED
12.1.5 FAIRHAVEN HEALTH
TABLE 134 FAIRHAVEN HEALTH: BUSINESS OVERVIEW
TABLE 135 FAIRHAVEN HEALTH: PRODUCTS OFFERED
12.1.6 FERTILITY FOCUS
TABLE 136 FERTILITY FOCUS: BUSINESS OVERVIEW
TABLE 137 FERTILITY FOCUS: PRODUCTS OFFERED
TABLE 138 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2016 TO DECEMBER 2020
TABLE 139 FERTILITY TEST MARKET: DEALS, JANUARY 2016 TO DECEMBER 2020
12.1.7 GERATHERM MEDICAL
TABLE 140 GERATHERM MEDICAL: BUSINESS OVERVIEW
FIGURE 35 GERATHERM MEDICAL: COMPANY SNAPSHOT (2019)
TABLE 141 EXCHANGE RATES: EUR TO USD
TABLE 142 GERATHERM MEDICAL: PRODUCTS OFFERED
12.1.8 HILIN LIFE PRODUCTS
TABLE 143 HILIN LIFE PRODUCTS: BUSINESS OVERVIEW
TABLE 144 HILIN LIFE PRODUCTS: PRODUCTS OFFERED
12.1.9 UEBE MEDICAL
TABLE 145 UEBE MEDICAL: BUSINESS OVERVIEW
TABLE 146 UEBE MEDICAL: PRODUCTS OFFERED
12.1.10 ADVACARE PHARMA
TABLE 147 ADVACARE PHARMA: BUSINESS OVERVIEW
TABLE 148 ADVACARE PHARMA: PRODUCTS OFFERED
12.1.11 AVA
TABLE 149 AVA: BUSINESS OVERVIEW
TABLE 150 AVA: PRODUCTS OFFERED
TABLE 151 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
TABLE 152 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.12 BABYSTART (SNOWDEN HEALTHCARE)
TABLE 153 BABYSTART: BUSINESS OVERVIEW
TABLE 154 BABYSTART: PRODUCTS OFFERED
12.1.13 VALLEY ELECTRONICS
TABLE 155 VALLEY ELECTRONICS: BUSINESS OVERVIEW
TABLE 156 VALLEY ELECTRONICS: PRODUCTS OFFERED
12.1.14 SENSIIA
TABLE 157 SENSIIA: BUSINESS OVERVIEW
TABLE 158 SENSIIA: PRODUCTS OFFERED
TABLE 159 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.15 MIRA CARE
TABLE 160 MIRA CARE: BUSINESS OVERVIEW
TABLE 161 MIRA CARE: PRODUCTS OFFERED
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES
12.2.1 EXSEED HEALTH
12.2.2 TEMPDROP
12.2.3 PREGMATE
12.2.4 MEDICAL ELECTRONIC SYSTEMS
12.2.5 SWIM COUNT (SUBSIDIARY OF MOTILTYCOUNT APS)
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Indicative list of secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 VOLUME-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: FERTILITY TEST MARKET
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 8 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 FERTILITY TEST MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 FERTILITY TEST MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE FERTILITY TEST MARKET
4 PREMIUM INSIGHTS
4.1 FERTILITY TEST MARKET OVERVIEW
FIGURE 13 INCREASING FIRST-TIME PREGNANCY AGE TO DRIVE MARKET GROWTH
4.2 FERTILITY TEST MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 14 OVULATION PREDICTION KITS SEGMENT TO DOMINATE THE MARKET IN 2025
4.3 APAC FERTILITY TEST MARKET SHARE, BY COUNTRY AND APPLICATION (2020)
FIGURE 15 FEMALE FERTILITY TESTING SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC FERTILITY TEST MARKET IN 2020
4.4 FERTILITY TEST MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 16 HOME CARE SETTINGS ARE THE LARGEST END USERS OF FERTILITY TESTING PRODUCTS
4.5 FERTILITY TEST MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing first-time pregnancy age
5.2.1.2 Declining fertility rates across the globe
FIGURE 19 DECLINE IN FERTILITY RATE IN THE US, 2008–2018
5.2.1.3 Growing population of women of reproductive age
5.2.1.4 Launch of advanced, easy-to-use fertility testing devices with high accuracy
5.2.1.5 Increasing awareness of fertility testing
5.2.1.6 Growing number of gynecological and reproductive issues in women and men
5.2.2 RESTRAINTS
5.2.2.1 Lesser precision of ovulation prediction kits
5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/
PCOD patients
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation
5.2.3.2 Emerging nations to offer new growth avenues
5.2.3.3 Online sales of fertility testing devices
5.2.3.4 High cost and low accuracy of IVF treatment
TABLE 1 COST OF IVF ACROSS VARIOUS COUNTRIES
5.2.4 CHALLENGES
5.2.4.1 High cost of fertility testing monitors
5.3 ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
5.4 REGULATORY ANALYSIS
5.4.1 US
TABLE 2 US FDA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 20 US: REGULATORY PROCESS FOR IVD DEVICES
5.4.2 CANADA
TABLE 3 CANADA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.3 EUROPE
TABLE 4 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 22 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
5.4.4 JAPAN
TABLE 5 CLASSIFICATION OF IVD REAGENTS IN JAPAN
5.4.5 CHINA
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 7 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.6 INDIA
FIGURE 23 INDIA: REGULATORY PROCESS FOR IVD DEVICES
5.5 VALUE CHAIN ANALYSIS
5.6 PRICING TREND ANALYSIS
TABLE 8 AVERAGE PRICE OF FERTILITY TESTING PRODUCTS, BY COUNTRY, 2020 (USD)
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 OVERVIEW
TABLE 9 FERTILITY TEST MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.2 THREAT OF NEW ENTRANTS
FIGURE 24 THREAT OF NEW ENTRANTS
5.7.3 THREAT OF SUBSTITUTES
FIGURE 25 THREAT OF SUBSTITUTES
5.7.4 BARGAINING POWER OF SUPPLIERS
FIGURE 26 BARGAINING POWER OF SUPPLIERS
5.7.5 BARGAINING POWER OF BUYERS
FIGURE 27 BARGAINING POWER OF BUYERS
5.7.6 DEGREE OF COMPETITION
FIGURE 28 DEGREE OF COMPETITION
5.8 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE
(AS OF 2019)
TABLE 10 NUMBER OF PATIENTS UTILIZING SPECIFIC FERTILITY TECHNIQUES WORLDWIDE (AS OF 2019)
5.9 COVID-19 IMPACT
6 FERTILITY TEST MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 11 FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 OVULATION PREDICTION KITS
6.2.1 LOW COST AND EASY AVAILABILITY OF OVULATION PREDICTION KITS TO DRIVE THEIR ADOPTION
TABLE 12 OVULATION PREDICTION KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 OVULATION PREDICTION KITS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 14 OVULATION PREDICTION KITS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 15 OVULATION PREDICTION KITS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3 FERTILITY MONITORS
TABLE 16 FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 17 FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 19 FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 20 FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.1 URINE-BASED FERTILITY MONITORS
6.3.1.1 Lower user-interpretation errors and fast and accurate results are advantages offered by urine-based monitors
TABLE 21 URINE-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 URINE-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 23 URINE-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 24 URINE-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.2 SALIVA-BASED FERTILITY MONITORS
6.3.2.1 Saliva-based monitors offer cost-effectiveness and better hygiene
TABLE 25 SALIVA-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 SALIVA-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 27 SALIVA-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 28 SALIVA-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.3 BLOOD-BASED FERTILITY MONITORS
6.3.3.1 Cost-effectiveness of blood-based monitors is expected to drive their adoption
TABLE 29 BLOOD-BASED FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 BLOOD-BASED FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 31 BLOOD-BASED FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 32 BLOOD-BASED FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.3.4 OTHER FERTILITY MONITORS
TABLE 33 OTHER FERTILITY MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 OTHER FERTILITY MONITORS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 35 OTHER FERTILITY MONITORS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 36 OTHER FERTILITY MONITORS MARKET, BY END USER, 2018–2025 (USD MILLION)
6.4 MALE FERTILITY TESTING PRODUCTS
6.4.1 MALE FERTILITY TESTING PRODUCTS TO ACCOUNT FOR THE LOWEST SHARE OF THE MARKET
TABLE 37 MALE FERTILITY TESTING PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 38 MALE FERTILITY TESTING PRODUCTS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 39 MALE FERTILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 40 MALE FERTILITY TESTING PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
7 FERTILITY TEST MARKET, BY MODE OF PURCHASE
7.1 INTRODUCTION
TABLE 41 FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
7.2 DIRECT/PRESCRIPTION PRODUCTS
7.2.1 AVAILABILITY OF INSURANCE COVERAGE FOR PRESCRIPTION REFILLS WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 42 DIRECT/PRESCRIPTION PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 OTC PRODUCTS
7.3.1 TREND OF SELF-MONITORING AND REMOTE ACCESS WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 43 OTC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 ONLINE PRODUCTS
7.4.1 INCREASING NUMBER OF E-PHARMACY PLATFORMS BOOSTING THE GROWTH OF THIS SEGMENT
TABLE 44 ONLINE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 FERTILITY TEST MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 45 FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 FEMALE FERTILITY TESTING
8.2.1 RISING PREVALENCE OF PCOD/PCOS WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 46 GLOBAL BURDEN OF PCOS, 2019 (PER MILLION)
TABLE 47 FERTILITY TEST MARKET FOR FEMALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
8.3 MALE FERTILITY TESTING
8.3.1 GROWING ADOPTION OF ADVANCED FERTILITY DEVICES TO AID THE GROWTH OF THIS SEGMENT
TABLE 48 FERTILITY TEST MARKET FOR MALE FERTILITY TESTING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
9 FERTILITY TEST MARKET, BY END USER
9.1 INTRODUCTION
TABLE 49 FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 HOME CARE SETTINGS
9.2.1 EASY ACCESS TO FERTILITY TESTING PRODUCTS THROUGH E-COMMERCE WEBSITES WILL STIMULATE THE GROWTH OF THIS SEGMENT
TABLE 50 FERTILITY TEST MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2025 (USD MILLION)
9.3 HOSPITALS AND FERTILITY CENTERS
9.3.1 INCREASING NUMBER OF FERTILITY CENTERS TO BOOST THE GROWTH OF THIS SEGMENT
TABLE 51 FERTILITY TEST MARKET FOR HOSPITALS AND FERTILITY CENTERS, BY REGION, 2018–2025 (USD MILLION)
9.4 OTHER END USERS
TABLE 52 FERTILITY TEST MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
10 FERTILITY TEST MARKET, BY REGION
10.1 INTRODUCTION
TABLE 53 FERTILITY TEST MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: FERTILITY TEST MARKET SNAPSHOT
TABLE 54 NORTH AMERICA: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 56 NORTH AMERICA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 58 NORTH AMERICA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 NORTH AMERICA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 High incidence of PCOD/PCOS will boost the growth of this market
TABLE 60 US: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 61 US: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Decreasing fertility rate and the increasing mean age of first-time pregnancies driving the market
TABLE 62 CANADA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 63 CANADA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3 EUROPE
TABLE 64 EUROPE: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 EUROPE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 69 EUROPE: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Increasing fertility concerns and awareness to drive market growth in Germany
TABLE 70 GERMANY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 71 GERMANY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Government initiatives and promotion of lab-based testing will stimulate market growth
TABLE 72 UK: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 73 UK: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing reforms for the management of POC tests to drive market growth in France
TABLE 74 FRANCE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 75 FRANCE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Decreasing fertility rates to drive the adoption of fertility testing devices in Italy
TABLE 76 ITALY: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 77 ITALY: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing awareness of fertility testing products among women to drive market growth
TABLE 78 SPAIN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 SPAIN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 80 ROE: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 ROE: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: FERTILITY TEST MARKET SNAPSHOT
TABLE 82 ASIA PACIFIC: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 ASIA PACIFIC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing average age of first-time pregnancies to drive market growth
TABLE 88 JAPAN: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 China dominated the Asia Pacific fertility test market in 2020
TABLE 90 CHINA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 CHINA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing prevalence of PCOD/PCOS to drive market growth in India
TABLE 92 INDIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 93 INDIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Supportive government initiatives and rising investments to drive market growth
TABLE 94 AUSTRALIA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 95 AUSTRALIA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Supportive government initiatives expected to positively impact market growth
TABLE 96 SOUTH KOREA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 SOUTH KOREA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 98 ROAPAC: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 ROAPAC: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5 LATIN AMERICA
TABLE 100 LATAM: FERTILITY TEST MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 101 LATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 102 LATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 LATAM: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 104 LATAM: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 105 LATAM: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Shrinking population concerns will drive market growth
TABLE 106 BRAZIL: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 107 BRAZIL: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing population to drive market growth in Mexico
TABLE 108 MEXICO: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 109 MEXICO: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 110 ROLATAM: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 ROLATAM: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES ARE EXPECTED TO RESTRAIN MARKET GROWTH IN MEA
TABLE 112 MEA: FERTILITY TEST MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 113 MEA: FERTILITY MONITORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 MEA: FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
TABLE 115 MEA: FERTILITY TEST MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 MEA: FERTILITY TEST MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY STRATEGIES
11.3 GLOBAL MARKET SHARE ANALYSIS (2019)
TABLE 117 FERTILITY TEST MARKET: DEGREE OF COMPETITION
FIGURE 31 SWISS PRECISION DIAGNOSTICS HELD THE LEADING POSITION IN THE FERTILITY TEST MARKET IN 2020
11.4 COMPETITIVE LEADERSHIP MAPPING
11.5 VENDOR INCLUSION CRITERIA
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 32 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/
START-UPS (2019)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 33 FERTILITY TEST MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
11.7 COMPANY PRODUCT FOOTPRINT ANALYSIS
TABLE 118 PRODUCT FOOTPRINT OF COMPANIES
TABLE 119 APPLICATION FOOTPRINT OF COMPANIES
TABLE 120 REGIONAL FOOTPRINT OF COMPANIES
11.8 COMPETITIVE SCENARIO
11.8.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
TABLE 121 FERTILITY TEST MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, 2017–2020
11.8.2 EXPANSIONS
TABLE 122 FERTILITY TEST MARKET: EXPANSIONS, 2017–2020
11.8.3 OTHER STRATEGIES
TABLE 123 FERTILITY TEST MARKET: OTHER STRATEGIES, 2017–2020
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
12.1.1 SWISS PRECISION DIAGNOSTICS
TABLE 124 SWISS PRECISION DIAGNOSTICS: BUSINESS OVERVIEW
TABLE 125 SWISS PRECISION DIAGNOSTICS: PRODUCTS OFFERED
TABLE 126 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
12.1.2 CHURCH & DWIGHT
TABLE 127 CHURCH & DWIGHT: BUSINESS OVERVIEW
FIGURE 34 CHURCH & DWIGHT: COMPANY SNAPSHOT (2020)
TABLE 128 CHURCH & DWIGHT: PRODUCTS OFFERED
12.1.3 PRESTIGE BRANDS HOLDINGS
TABLE 129 PRESTIGE BRANDS HOLDINGS: BUSINESS OVERVIEW
TABLE 130 PRESTIGE BRANDS HOLDINGS: PRODUCTS OFFERED
TABLE 131 FERTILITY TESTS MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.4 BIOZHENA
TABLE 132 BIOZHENA: BUSINESS OVERVIEW
TABLE 133 BIOZHENA: PRODUCTS OFFERED
12.1.5 FAIRHAVEN HEALTH
TABLE 134 FAIRHAVEN HEALTH: BUSINESS OVERVIEW
TABLE 135 FAIRHAVEN HEALTH: PRODUCTS OFFERED
12.1.6 FERTILITY FOCUS
TABLE 136 FERTILITY FOCUS: BUSINESS OVERVIEW
TABLE 137 FERTILITY FOCUS: PRODUCTS OFFERED
TABLE 138 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2016 TO DECEMBER 2020
TABLE 139 FERTILITY TEST MARKET: DEALS, JANUARY 2016 TO DECEMBER 2020
12.1.7 GERATHERM MEDICAL
TABLE 140 GERATHERM MEDICAL: BUSINESS OVERVIEW
FIGURE 35 GERATHERM MEDICAL: COMPANY SNAPSHOT (2019)
TABLE 141 EXCHANGE RATES: EUR TO USD
TABLE 142 GERATHERM MEDICAL: PRODUCTS OFFERED
12.1.8 HILIN LIFE PRODUCTS
TABLE 143 HILIN LIFE PRODUCTS: BUSINESS OVERVIEW
TABLE 144 HILIN LIFE PRODUCTS: PRODUCTS OFFERED
12.1.9 UEBE MEDICAL
TABLE 145 UEBE MEDICAL: BUSINESS OVERVIEW
TABLE 146 UEBE MEDICAL: PRODUCTS OFFERED
12.1.10 ADVACARE PHARMA
TABLE 147 ADVACARE PHARMA: BUSINESS OVERVIEW
TABLE 148 ADVACARE PHARMA: PRODUCTS OFFERED
12.1.11 AVA
TABLE 149 AVA: BUSINESS OVERVIEW
TABLE 150 AVA: PRODUCTS OFFERED
TABLE 151 FERTILITY TEST MARKET: PRODUCT LAUNCHES, JANUARY 2017 TO DECEMBER 2020
TABLE 152 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.12 BABYSTART (SNOWDEN HEALTHCARE)
TABLE 153 BABYSTART: BUSINESS OVERVIEW
TABLE 154 BABYSTART: PRODUCTS OFFERED
12.1.13 VALLEY ELECTRONICS
TABLE 155 VALLEY ELECTRONICS: BUSINESS OVERVIEW
TABLE 156 VALLEY ELECTRONICS: PRODUCTS OFFERED
12.1.14 SENSIIA
TABLE 157 SENSIIA: BUSINESS OVERVIEW
TABLE 158 SENSIIA: PRODUCTS OFFERED
TABLE 159 FERTILITY TEST MARKET: DEALS, JANUARY 2017 TO DECEMBER 2020
12.1.15 MIRA CARE
TABLE 160 MIRA CARE: BUSINESS OVERVIEW
TABLE 161 MIRA CARE: PRODUCTS OFFERED
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES
12.2.1 EXSEED HEALTH
12.2.2 TEMPDROP
12.2.3 PREGMATE
12.2.4 MEDICAL ELECTRONIC SYSTEMS
12.2.5 SWIM COUNT (SUBSIDIARY OF MOTILTYCOUNT APS)
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
